Autism Research and Treatment / 2016 / Article / Fig 2

Clinical Study

Illness Severity, Social and Cognitive Ability, and EEG Analysis of Ten Patients with Rett Syndrome Treated with Mecasermin (Recombinant Human IGF-1)

Figure 2

Combined features of social and cognitive scores before and after treatment for IGF1 treated patients in comparison to untreated patients. The change in Rett Severity Score (RSS) was significant for RSS 1–3 () as analysed by Wilcoxon Matched-Pairs Signed Ranks Test. A higher score correlates to better social/cognitive ability.